The fuzzy frontier between subjective memory complaints and early dementia: A survey of patient management in German memory clinics

Dementia and Geriatric Cognitive Disorders

Volumn 17, Issue 3, 2004, Pages 222-230

  Rosler A ^a,b,c   Gonnenwein C ^a   Muller N ^a   Sterzer, P ^a   Kleinschmidt, A ^a   Frolich L ^a  

^a GOETHE UNIVERSITY   (Germany)

^b Albertinen Haus   (Germany)

^c UNIVERSITY HOSPITAL FRANKFURT   (Germany)

Author keywords

Cognition; Dementia; Driving; Memory; Mild cognitive impairment

Indexed keywords

AGED; ALZHEIMER DISEASE; ANAMNESIS; ARTICLE; CASE REPORT; CLINICAL EXAMINATION; CLINICAL FEATURE; DAILY LIFE ACTIVITY; DEMENTIA; DISEASE COURSE; DISEASE SEVERITY; DRIVING ABILITY; FEMALE; FOLLOW UP; HUMAN; LABORATORY TEST; MALE; MEMORY DISORDER; NEUROIMAGING; NEUROLOGIC EXAMINATION; NEUROPSYCHOLOGICAL TEST; PRIORITY JOURNAL; RISK ASSESSMENT; SCORING SYSTEM;

ACTIVITIES OF DAILY LIVING; AGED; AUTOMOBILE DRIVING; DEMENTIA; FEMALE; HUMANS; MAGNETIC RESONANCE IMAGING; MALE; MEMORY DISORDERS; NEUROPSYCHOLOGICAL TESTS; QUESTIONNAIRES; TOMOGRAPHY, EMISSION-COMPUTED; TOMOGRAPHY, X-RAY COMPUTED;

EID: 17744409382     PISSN: 14208008     EISSN: None     Source Type: Journal    
DOI: 10.1159/000076360     Document Type: Article

References (41)

1. Petersen RC, Smith GE, Waring SC, et al: Mild cognitive impairment: Clinical characterization and outcome. Arch Neurol 1999;56:303-308.
2. Devanand DP, Folz M, Gorlyn M, et al: Questionable dementia: Clinical course and predictors of outcome. J Am Geriatr Soc 1997;45:321-328.
3. Gutierrez R, Atkinson JH, Grant I: Mild neurocognitive disorder: Needed addition to the nosology of cognitive impairment (organic mental) disorders. J Neuropsychiatry Clin Neurosci 1993;5:161-177.
4. Linn RT, Wolf PA, Bachman DL, et al: The 'preclinical phase' of probable Alzheimer's disease. A 13-year prospective study of the Framingham cohort. Arch Neurol 1995;52:485-490.
5. Crook TH, Bartus RT, LaRue A: Age-associated memory impairment: Proposed diagnostic criteria and measures of clinical change: Report of the National Institute of Mental Health work group. Dev Neuropsychol 1986;2:261-276.
6. Kral VA: Senescent forgetfulness: Benign and malignant. Can Med Assoc J 1962;86:257-260.
7. Levy R: Ageing-associated cognitive decline. Int Psychogeriatr 1994;6:63-68.
8. Ritchie K, Artero S, Touchon J: Classification criteria for mild cognitive impairment: A population-based validation study. Neurology 2001;56:37-42.
9. Morris JC, Storandt M, Miller JP, et al: Mild cognitive impairment represents early-stage Alzheimer disease. Arch Neurol 2001;58:397-405.
10. Tierney MC, Szalai JP, Snow WG, et al: Prediction of probable Alzheimer's disease in memory-impaired patients: A prospective longitudinal study. Neurology 1996;46:61-65.
11. Petersen RC, Stevens JC, Ganguli M, et al: Practice parameter: Early detection of dementia: Mild cognitive impairment (an evidence-based review). Neurology 2001;56:1133-1142.
12. Galasko D, Hansen LA, Katzman R, et al: Clinical-neuropathological correlations in Alzheimer's disease and related dementias. Arch Neurol 1994;51:888-895.
13. Klatka LA, Schiffer RB, Powers JM, Kazee AM: Incorrect diagnosis of Alzheimer's disease: A clinicopathologic study. Arch Neurol 1996;53:35-42.
14. Doraiswamy PM: Interventions for mild cognitive impairment and Alzheimer disease: New strategies, new hope. Am J Geriatr Psychiatry 2003;11:120-122.
15. Burns A, Zaudig M: Mild cognitive impairment in older people. Lancet 2002;360:1963-1965.
16. Palmer K, Fratiglioni L, Winblad B: What is mild cognitive impairment? Variations in definitions and evolution of nondemented persons with cognitive impairment. Acta Neurol Scand Suppl 2003;179:14-20.
17. McGlone J, Gupta S, Humphrey D, et al: Screening for early dementia using memory complaints from patients and relatives. Arch Neurol 1990;47:1189-1193.
18. Carr DB, Gray S, Baty J, et al: The value of informant versus individual's complaints of memory impairment in early dementia. Neurology 2000;55:1724-1726.
19. Schmand B, Jonker C, Hooijer C, et al: Subjective memory complaints may announce dementia. Neurology 1996;46:121-125.
20. Jonker C, Geerlings MI, Schmand B: Are memory complaints predictive for dementia? A review of clinical and population-based studies. Int J Geriatr Psychiatry 2000;15:983-991.
21. Edelberg HK, Shallenberger E, Wei JY: Medication management capacity in highly functioning community-living older adults: Detection of early deficits. J Am Geriatr Soc 1999;47:592-596.
22. Barberger-Gateau P, Fabrigoule C, Rouch I, et al: Neuropsychological correlates of self-reported performance in instrumental activities of daily living and prediction of dementia. J Gerontol B Psychol Sci Soc Sci 1999;54:293-303.
23. Nygard L: Instrumental activities of daily living: A stepping-stone towards Alzheimer's disease diagnosis in subjects with mild cognitive impairment? Acta Neurol Scand Suppl 2003;179:42-46.
24. Albert SM, Tabert MH, Dienstag A, et al: The impact of mild cognitive impairment on functional abilities in the elderly. Curr Psychiatry Rep 2002;4:64-68.
25. Jack CR, Petersen RC, Xu YC, et al: Prediction of AD with MRI-based hippocampal volume in mild cognitive impairment. Neurology 1999;52:1397-1403.
26. Laakso MP: Structural imaging in cognitive impairment and the dementias: An update. Curr Opin Neurol 2002;15:415-421.
27. Killiany RJ, Gomez-Isla T, Moss M, et al: Use of structural magnetic resonance imaging to predict who will get Alzheimer's disease. Ann Neurol 2000;47:430-439.
28. Killiany RJ, Hyman BT, Gomez-Isla T, et al: MRI measures of entorhinal cortex vs. hippocampus in preclinical AD. Neurology 2002;58:1188-1196.
29. Chetelat G, Desgranges B, De La Sayette V, Viader F, Eustache F, Baron JC: Mild cognitive impairment: Can FDG-PET predict who is to rapidly convert to Alzheimer's disease? Neurology 2003;60:1374-1377.
30. Sachdev PS, Valenzuela MJ, Brodaty H, et al: Homocysteine as a risk factor for cognitive impairment in stroke patients. Dement Geriatr Cogn Disord 2003;15:155-162.
31. McCaddon A, Davies G, Hudson P, et al: Total serum homocysteine in senile dementia of Alzheimer type. Int J Geriatr Psychiatry 1998;13:235-239.
32. Kessler H, Bleich S, Falkai P, et al: Homocysteine and dementia (in German). Fortschr Neurol Psychiatr 2003;71:150-156.
33. Andreasen N, Vanmechelen E, Vanderstichele H, et al: Cerebrospinal fluid levels of total-τ, phospho-τ and Aβ42 predicts development of Alzheimer's disease in patients with mild cognitive impairment. Acta Neurol Scand 2003;107(suppl 179):47-51.
34. Jelic V, Winblad B: Treatment of mild cognitive impairment: Rationale, present and future strategies. Acta Neurol Scand Suppl 2003;179:83-93.
35. Davis KL, Mohs RC, Marin D, et al: Cholinergic markers in elderly patients with early signs of Alzheimer disease. JAMA 1999;281:1401-1406.
36. Mufson EJ, Ma SY, Dills J, et al: Loss of basal forebrain P75(NTR) immunoreactivity in subjects with mild cognitive impairment and Alzheimer's disease. J Comp Neurol 2002;443:136-153.
37. DeKosky ST, Ikonomovic MD, Styren SD, et al: Upregulation of choline acetyltransferase activity in hippocampus and frontal cortex of elderly subjects with mild cognitive impairment. Ann Neurol 2002;51:145-155.
38. Tabet N, Birks J, Evans JG: Vitamin E for Alzheimer' s disease. Cochrane Database Syst Rev 2000;4:CD002854.
39. Morris MC, Evans DA, Bienias JL, et al: Dietary intake of antioxidant nutrients and the risk of incident Alzheimer disease in a biracial community study. JAMA 2002;287:3230-3237.
40. Rapp S, Brenes G, Marsh AP: Memory enhancement training for older adults with mild cognitive impairment: A preliminary study. Aging Ment Health 2002;6:5-11.
41. Johansson K, Lundberg C: The 1994 International Consensus Conference on Dementia and Driving: A brief report. Swedish National Road Administration. Alzheimer Dis Assoc Disord 1997;11(suppl 1):62-69.